Latest Period
Q2 2026
CUSIP: 15117N701
Latest Period
Q2 2026
Institutions Reporting
21
Shares (Excl. Options)
284,342
Price
$1.78
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
Latest holder context comes from 21 institutions filings for Q2 2026.
Security key
15117N701
Latest holder period
Q2 2026
13F holders
21
13D/G owners
1
CIK / CUSIP context first
Broader feeds
Open recent reporting periods for CUSIP 15117N701:
13D/G owners
Large-stake holder rows connected to Schedule 13D/G evidence.
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | 0% | $927,649 | +$206,820 | 450,315 | +29% | Armistice Capital, LLC | 30 Jun 2026 |
As of 30 Jun 2026, 21 institutional investors reported holding 284,342 shares of Imunon, Inc. - Common stock, par value $0.01 per share (IMNN). This represents 6.3% of the company’s total 4,507,658 outstanding shares.
Quarter history
Holder count, reported shares/value, and median price by quarter.
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 284,342 | $506,061 | -$342,747 | $1.78 | 21 |
| 2026 Q1 | 469,246 | $1,379,146 | +$87,699 | $2.94 | 17 |
| 2025 Q4 | 397,576 | $1,514,770 | +$1,045,862 | $3.81 | 18 |
| 2025 Q3 | 157,420 | $879,048 | +$807,689 | $5.13 | 16 |
| 2025 Q2 | 13,911 | $11,129 | +$11,129 | $0.80 | 1 |